Position in GILD
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$4,449,189
-$408,970 QoQ
Shares Held
35,216
+1.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#611
of 2,275 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Carnegie Investment Counsel holds $159,457,484 across 11 Drug Manufacturers - General names. GILD ranks #7 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
182,419 | $45,903,917 | |
| 2 | AMGN |
Amgen Inc
|
103,528 | $37,489,559 | |
| 3 | JNJ |
Johnson & Johnson
|
132,112 | $33,552,484 | |
| 4 | LLY |
ELI LILLY & Co
|
11,114 | $13,330,466 | |
| 5 | MRK |
Merck & Co., Inc.
|
71,923 | $9,242,105 | |
| 6 | NVO |
Novo Nordisk A S
|
170,256 | $8,162,072 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
35,216 | $4,449,189 | |
| 8 | PFE |
Pfizer Inc
|
129,803 | $3,125,656 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,449,189 | 35,216 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $4,858,159 | 34,858 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $4,342,418 | 35,379 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $3,922,629 | 35,339 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $3,831,999 | 34,563 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $3,641,400 | 32,498 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $2,992,418 | 32,396 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $2,728,824 | 32,548 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $2,152,638 | 31,375 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $2,267,014 | 30,949 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $2,419,768 | 29,870 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $2,264,611 | 30,219 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $1,969,986 | 25,561 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $2,050,935 | 24,719 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $2,156,208 | 25,116 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $1,631,021 | 26,439 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $410,047 | 6,634 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $358,186 | 6,025 | Shares | Sole | 2022-04-11 | |
| 2021-12-31 | $460,783 | 6,346 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $395,630 | 5,664 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $390,023 | 5,664 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $399,736 | 6,185 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $491,772 | 8,441 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $549,184 | 8,691 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $712,310 | 9,258 | Shares | Sole | 2020-07-09 | |
| 2020-03-31 | $610,340 | 8,164 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||